Literature DB >> 11468044

Outcome following surgical closure of secundum atrial septal defect.

D A Jones1, D J Radford, P G Pohlner.   

Abstract

OBJECTIVE: To assess the current outcome of surgical closure of secundum atrial septal defects (ASD) in an Australian paediatric population.
METHODOLOGY: A retrospective chart review of 87 children, aged 2 months to 15 years, was performed for surgery between August 1995 and March 1999.
RESULTS: There were no deaths in the patients studied. Approximately one in four patients (24.1%) experienced complications requiring further management. Complication rates were similar to those published previously. However, one in nine patients (11.5%) required surgical drainage of a pericardial effusion. A total of five of 87 (5.7%) patients developed post-pericardiotomy syndrome (PPS), of whom four required pericardiocentesis. The risk for developing a pericardial effusion requiring drainage or PPS was more than twice in children older than 5 years of age at the time of surgery compared to those aged under 5 years, although there was an insufficient number of subjects in the study to prove this statistically (Odds ratio 2.31).
CONCLUSIONS: Most patients have an uncomplicated postoperative course following surgical closure of secundum ASD. However, a significant minority (24.1%) do develop complications requiring further management and have a correspondingly longer period of hospitalization. Patients older than 5 years of age were identified as being potentially at greater risk for the development of PPS or a pericardial effusion requiring drainage. Further research needs to be performed to clarify this.

Entities:  

Mesh:

Year:  2001        PMID: 11468044     DOI: 10.1046/j.1440-1754.2001.00659.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  7 in total

1.  Does Prophylactic Ibuprofen After Surgical Atrial Septal Defect Repair Decrease the Rate of Post-Pericardiotomy Syndrome?

Authors:  Edon J Rabinowitz; David B Meyer; Priya Kholwadwala; Nina Kohn; Adnan Bakar
Journal:  Pediatr Cardiol       Date:  2018-06-14       Impact factor: 1.655

2.  Prevalence and Risk Factors for Pericardial Effusions Requiring Readmission After Pediatric Cardiac Surgery.

Authors:  Matthew D Elias; Andrew C Glatz; Matthew J O'Connor; Susan Schachtner; Chitra Ravishankar; Christoper E Mascio; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2016-11-30       Impact factor: 1.655

3.  Recent Experience and Follow-Up After Surgical Closure of Secundum Atrial Septal Defect in 120 Children.

Authors:  Geoffroy de Beco; Natasha Mambour; Christophe Vô; Laetitia Vanhoutte; Stéphane Moniotte; Alain Poncelet; Thierry Sluysmans
Journal:  Pediatr Cardiol       Date:  2018-05-22       Impact factor: 1.655

Review 4.  Catheters, wires, tubes and drains on postoperative radiographs of pediatric cardiac patients: the whys and wherefores.

Authors:  Sarah A Teele; Sitaram M Emani; Ravi R Thiagarajan; Rita L Teele
Journal:  Pediatr Radiol       Date:  2008-03-15

5.  Early Surgical Closure of Atrial Septal Defect Improves Clinical Status of Symptomatic Young Children with Underlying Pulmonary Abnormalities.

Authors:  Takeshi Tsuda; Ryan R Davies; Wolfgang Radtke; Christian Pizarro; Abdul M Bhat
Journal:  Pediatr Cardiol       Date:  2020-05-09       Impact factor: 1.655

6.  Incidence and predictors of pericardial effusion following surgical closure of atrial septal defect in children: A single center experience.

Authors:  Martina Campisano; Camilla Celani; Alessio Franceschini; Denise Pires Marafon; Silvia Federici; Gianluca Brancaccio; Lorenzo Galletti; Fabrizio De Benedetti; Marcello Chinali; Antonella Insalaco
Journal:  Front Pediatr       Date:  2022-08-09       Impact factor: 3.569

7.  Pericardial effusion after congenital heart surgery.

Authors:  Mio Noma; Yasutaka Hirata; Norimichi Hirahara; Takaaki Suzuki; Hiroaki Miyata; Yuji Hiramatsu; Yukihiro Yoshimura; Shinichi Takamoto
Journal:  JTCVS Open       Date:  2022-01-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.